Literature DB >> 8859197

Non-Hodgkin's lymphomas in Thailand. A retrospective pathologic and clinical analysis of 1391 cases.

T Intragumtornchai1, P Wannakrairoj, B Chaimongkol, L Bhoopat, A Lekhakula, T Thamprasit, N Suwanwela, C Suthipinthawong, W Prayoonwiwat, P Meekungwal, C Sirijerachai, C Pairojkul.   

Abstract

BACKGROUND: Geographic variations in the histopathologic pattern of non-Hodgkin's lymphoma (NHL) are well documented. Insight into this epidemiologic data might shed light on the underlying etiology. Currently, there is a paucity of information regarding the pattern of NHL occurring in Thailand and Southeast Asia. The current nationwide study was undertaken to obtain a clearer definition of the disease among Thais and to compare this information with data from other Asian and Western countries.
METHODS: A retrospective analysis of histopathologic subtypes and clinical features was conducted in 1391 patients (age > or = 15 years) with NHL, who were treated at 6 major medical centers in 4 representative areas of Thailand. One hundred and thirty unselected cases were immunohistochemically studied. The reports from other countries used for comparison were identified through a computerized search on MEDLINE.
RESULTS: Of the total cases studied, follicular lymphomas constituted 3.8% and diffuse lymphomas 91.4%. The frequency of low and intermediate grade (including large cell immunoblastic, using the Working Formulation) were 12.8% and 72.9%, respectively. The most common histologic subtype was the diffuse large cell and large cell immunoblastic entity, which constituted 39.9% of the cases studied. The rate of small lymphocytic and diffuse small cleaved subtypes were higher than in the United States. Of the 130 cases studied, T-cell lymphoma comprised 16.1%, which was much less than in Japan, China, or Taiwan.
CONCLUSIONS: The histopathologic pattern of NHL in Thailand was characterized by the features noted for Asia, i.e., a low rate of the follicular entity and a preponderance of the diffuse aggressive subtypes. In addition, the frequency of the small lymphocytic and diffuse small cleaved subtypes were increased compared with the Western population and the rate of T-cell lymphoma appeared to be less than in Far East Asia.

Entities:  

Mesh:

Year:  1996        PMID: 8859197

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Diffuse large B-cell lymphoma: experience from a tertiary care center in North India.

Authors:  Rohan Khera; Snigdha Jain; Lalit Kumar; S Thulkar; M Vijayraghwan; R Dawar
Journal:  Med Oncol       Date:  2009-04-07       Impact factor: 3.064

2.  Analysis of follicular lymphoma by dual-color fluorescence in situ hybridization.

Authors:  Dakeun Lee; Jinwon Seo; YoungLyun Oh; Jinman Kim; YoungHyeh Ko
Journal:  Virchows Arch       Date:  2007-11-27       Impact factor: 4.064

3.  A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China.

Authors:  Sherilyn A Gross; Xiongzeng Zhu; Liming Bao; John Ryder; Anh Le; Yan Chen; Xiao Qin Wang; Richard D Irons
Journal:  Int J Hematol       Date:  2008-07-23       Impact factor: 2.490

4.  High frequency of BCL2 translocation in Thai patients with follicular lymphomas.

Authors:  Ponlapat Rojnuckarin; Thamatorn Assanasen; Atcharaporn Chotipuech; Preecha Ruangvejvorachai; Montakarn Tansatit; Pongsak Wannakrairot; Tanin Intragumtornchai
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

5.  Japanese case of follicular lymphoma of ocular adnexa diagnosed by clinicopathologic, immunohistochemical, and molecular genetic techniques.

Authors:  Takaaki Otomo; Nobuo Fuse; Kenichi Ishizawa; Motohiko Seimiya; Masahiko Shimura; Ryo Ichinohasama
Journal:  Clin Ophthalmol       Date:  2010-12-01

6.  The epidemiological features of lymphoid malignancies in Benin City, Nigeria: a 15 years study.

Authors:  Caroline Edijana Omoti; Alexander Ikenna Nwannadi; Jude Chike Obieche; Adesuwa Noma Olu-Eddo
Journal:  Pan Afr Med J       Date:  2012-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.